ArticlePloS one2025

Evaluation of adverse events and comorbidity exacerbation following the COVID-19 booster dose: A national survey among randomly-selected booster recipients.

Dvora Frankenthal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.